General Hospital of Ioannina G. Hatzikosta
In research, General Hospital of Ioannina G. Hatzikosta stands highest in Health Sciences (#11,386 of 11,982 worldwide), 2022–2025.
- World rank, 2022–2025
- #25,142 of 28,054 · #34,803 all time
- Rank in Greece
- #118 of 124
- Research works
- 361 ▲ 52% vs 2013–17
- Citations
- 7.2k 20.0 per fractional work
- Top-10% rate
- 6.9% record average 16.5%
- Open access
- 39% world 28%
What is General Hospital of Ioannina G. Hatzikosta known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #11,386 of 11,982 | 6.2% | 62 | #15186 |
Each strip is that field’s whole ranked pool, with the notch where General Hospital of Ioannina G. Hatzikosta sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.1×. Every wedge is a field page.
- Medicine 4.1×
- Nursing 4.1×
- Veterinary 3.4×
- Immunology and Microbiology 2.2×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Neuroscience 1.2×
- Health Professions 1.0×
- Psychology 0.3×
- Environmental Science 0.2×
- Pharmacology, Toxicology and Pharmaceutics 0.2×
- Mathematics 0.1×
- Social Sciences 0.1×
- Earth and Planetary Sciences 0.1×
- Engineering 0.1×
- Business, Management and Accounting 0.1×
Which keywords describe research at General Hospital of Ioannina G. Hatzikosta?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Treatment, Complications, Autoantibodies, Mortality, Inflammation, Rehabilitation and Surgical Treatment.
- Systemic Lupus Erythematosus
- Diagnostic Imaging
- Rheumatoid Arthritis
- Fibrosis
- Disease-Modifying Antirheumatic Drugs
- Quality Improvement
- Cancer Risk
- Osteoarthritis
- Atherosclerosis
- Immunosuppressive Therapy
- Cardiovascular Risk
- Surgical Management
- Clinical Practice Guidelines
- Risk Factors
- Cytokines
- Surgical Treatment
- Rehabilitation
- Mortality
- Autoantibodies
- Treatment
- Epidemiology
- Inflammation
- Complications
- Diagnosis
- Guidelines
- Quality of Life
- Imaging
- Genetic Mutations
- Management
- Biological Therapy
- Immune Response
- Pathophysiology
- Elderly Patients
- Ankylosing Spondylitis
- Internal Fixation
- Spondyloarthritis
- Endothelial Dysfunction
- Joint Inflammation
- Antiphospholipid Syndrome
- Radiation Exposure
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology10▲ 3.6×40 topics
- Treatment6▲ 6.9×20 topics
- Inflammation6▲ 3.9×18 topics
- Autoantibodies4▲ 25×5 topics
- Complications4▲ 12×8 topics
- Mortality4▲ 10×8 topics
- Diagnosis3▲ 4.1×12 topics
- Rehabilitation3▲ 8.9×6 topics
- Guidelines2▲ 7.4×9 topics
- Surgical Treatment2▲ 17×5 topics
- Quality of Life2▲ 2.3×12 topics
- Cytokines2▲ 11×4 topics
- Imaging2▲ 12×4 topics
- Risk Factors2▲ 2.8×7 topics
- Genetic Mutations2▲ 6.9×9 topics
- Clinical Practice Guidelines2▲ 5.2×9 topics
- Management2▲ 3.5×10 topics
- Surgical Management2▲ 6.8×8 topics
- Biological Therapy2▲ 45×2 topics
- Cardiovascular Risk2▲ 8.2×4 topics
- Immune Response2▲ 4.5×6 topics
- Immunosuppressive Therapy2▲ 13×3 topics
- Pathophysiology2▲ 8.3×6 topics
- Atherosclerosis2▲ 7.6×4 topics
- Elderly Patients2▲ 13×3 topics
- Osteoarthritis2▲ 17×2 topics
- Ankylosing Spondylitis2▲ 75×1 topic
- Cancer Risk2▲ 9.1×4 topics
- Internal Fixation2▲ 30×2 topics
- Quality Improvement2▲ 11×3 topics
- Spondyloarthritis2▲ 75×1 topic
- Disease-Modifying Antirheumatic Drugs1▲ 37×1 topic
- Endothelial Dysfunction1▲ 8.1×3 topics
- Fibrosis1▲ 11×3 topics
- Joint Inflammation1▲ 37×1 topic
- Rheumatoid Arthritis1▲ 20×2 topics
- Antiphospholipid Syndrome1▲ 38×1 topic
- Diagnostic Imaging1▲ 16×2 topics
- Radiation Exposure1▲ 18×2 topics
- Systemic Lupus Erythematosus1▲ 34×1 topic
Which research topics does General Hospital of Ioannina G. Hatzikosta publish most on?
By volume in 2022–2025: Spondyloarthritis Studies and Treatments, Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research and Systemic Sclerosis and Related Diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Spondyloarthritis Studies and Treatments Rheumatology 2 works
- 2 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
- 3 Systemic Lupus Erythematosus Research Rheumatology 1 works
- 4 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 1 works
- 5 Cardiac, Anesthesia and Surgical Outcomes Cardiology and Cardiovascular Medicine 1 works
- 6 Hip disorders and treatments Surgery 1 works
- 7 Orthopedic Surgery and Rehabilitation Surgery 1 works
- 8 Nursing Diagnosis and Documentation Issues, ethics and legal aspects 1 works
- 9 Hip and Femur Fractures Surgery 1 works
- 10 Musculoskeletal synovial abnormalities and treatments Rheumatology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has General Hospital of Ioannina G. Hatzikosta's research output changed?
Output in 2018–2022 was 52% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Ioannina
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.